Phase II Preview For Roche's Dalcetrapib May Give CETP Inhibition A Boost
This article was originally published in The Pink Sheet Daily
Executive Summary
European Society of Cardiology Congress abstract for small study suggests Roche's dalcetrapib is safe and works on plaque burden.